Secunderabad, India

Umamaheshwar P Mokkapati

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Bengaluru, IN (2013)
  • Andhra Pradesh, IN (2016)
  • Secunderabad, IN (2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Umamaheshwar P Mokkapati: Innovator in Tricyclic Indole Derivatives

Introduction

Umamaheshwar P Mokkapati is a notable inventor based in Secunderabad, India. He has made significant contributions to the field of chemistry, particularly in the development of tricyclic indole derivatives. With a total of 3 patents to his name, Mokkapati's work has implications for therapeutic and diagnostic applications.

Latest Patents

Mokkapati's latest patents include a crystallization process for tricyclic indole derivatives. This composition boasts higher purity and a better impurity profile compared to existing compositions, resulting in superior properties for in vivo applications. Another significant patent involves a zinc halide mediated cyclization process that enhances the production of tricyclic indole compounds, improving upon known methods.

Career Highlights

He is currently associated with GE Healthcare Limited, where he continues to innovate and contribute to advancements in his field. His work is pivotal in enhancing the quality and efficacy of chemical compounds used in medical applications.

Collaborations

Mokkapati has collaborated with notable colleagues, including Afsal Mohammed Kadavilpparampu Mohamed and Sondre Nilsen, further enriching his research and development efforts.

Conclusion

Umamaheshwar P Mokkapati's contributions to the field of tricyclic indole derivatives highlight his innovative spirit and dedication to advancing medical chemistry. His patents reflect a commitment to improving therapeutic agents, making a significant impact in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…